ProCE Banner Series

Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

Register now to join your colleagues for this CME-presentation providing expert guidance on individualizing management of adult patients with spinal muscular atrophy.

  AMA
Credits Available

1.0

Who Should Attend

The intended audience for this educational initiative is neurologists who manage patients with spinal muscular atrophy.

All Events

Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

Upcoming Events

February

21

2024

6:30 PM - 7:30 PM Eastern Time (ET)

Virtual

February

25

2024

7:00 AM - 8:00 AM Eastern Time (ET)

In-person

Grandover Resort, 1000 Club Road, Greensboro, North Carolina 27407

March

23

2024

12:00 PM - 1:00 PM Pacific Time (PT)

In-person

The Meritage, 875 Bordeaux Way, Napa, California 94558

May

09

2024

6:30 PM - 7:30 PM Eastern Time (ET)

Virtual

Past Events

November

11

2023

6:00 PM - 7:00 PM Eastern Time (ET)

In-person

Valley Forge Casino Resort, 1160 1st Avenue, King of Prussia, Pennsylvania 19406

February

08

2024

6:00 PM - 7:00 PM Pacific Time (PT)

Virtual

Faculty

ProCE Banner Faculty
Michael Cartwright, MD, MS

Professor of Neurology
Wake Forest School of Medicine
Winston-Salem, North Carolina

ProCE Banner Faculty
Lauren Elman, MD

Professor of Neurology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

ProCE Banner Faculty
Perry Shieh, MD, PhD

Professor (Health Sciences)
Departments of Neurology and Pediatrics
David Geffen School of Medicine at UCLA
University of California, Los Angeles
Los Angeles, California

Topics

  • SMA overview, SMA type IV  
  • Disease burden, clinical and psychosocial impact
    • Adult specific factors to consider – occupational/career, family planning 
  • Treatment options   
    • Safety and efficacy of available and emerging treatments for adults with SMA 
      • Risdiplam, nusinersen
      • Clinical updates of note 
    • Psychosocial support for patients with SMA 
  • Factors to consider when developing/modifying treatment plans   
    • Goals, disease progression 
    • Patient factors/preferences 
    • Patient engagement: How to foster this (shared decision-making, communication strategies) 
    • Case example(s)

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
Neurologists need to modify their clinical approach to provide individualized care within the context of new treatments. The number of adults with SMA is expected to continue to grow, and thus, a greater need exists for clinicians to improve their provision of age-appropriate care and ensure adults benefit from therapeutic advances. This educational initiative will provide targeted, clear, and concise information that would help neurologists provide optimal, individualized care to their adult patients with SMA.

Target Audience
The intended audience for this educational initiative is neurologists who manage patients with spinal muscular atrophy. 

Learning Objectives:

  • Discuss the unique clinical issues and psychosocial needs faced by adults with SMA
  • Assess the latest safety and efficacy data of available and emerging disease-modifying therapies for SMA in adults
  • Integrate available disease-modifying therapies for SMA into individualized, evidence-based treatment plans
  • Apply effective communication strategies to engage patients in shared decision making and reach management decisions that meet their individual needs

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and Cure SMA. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABMS MOC RECOGNITION STATEMENT
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Spinal Muscular Atrophy Optimizing the Management of Adults in the Era of Disease-Modifying Therapies has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

ABMS Lifelong Learning CME Activity
Psychiatry and Neurology

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, in partnership with Cure SMA

Supported by educational grants from Biogen and Genentech, a member of the Roche Group.